For Tony Arnerich, the baseball analogy is apt. Two years ago, in arguably the late innings of his 30-plus-year investment consulting career, he hit what he describes as a game-winning home-run: an investment he made on behalf of several clients in a biotech company returned approximately $200m in profit. To...